In NSCLC, the PI3K/AKT pathway has been implicated in both tumorigenesis and the progression of disease, and somatic mutations of PIK3CA and amplifications of PIK3CA are frequently found in patients with NSCLC [31]. Here, AKT1 is linked to non-small cell lung carcinoma.